Health Tech IP
is life-critical.
In medical devices and diagnostics, your IP portfolio is not just a competitive moat - it's the primary asset that determines whether you can bring your product to patients without a well-funded competitor replicating it first.
Device patents
Hardware architecture, sensor configurations, signal processing methods, and form factors are patentable. We file provisionals early - before FDA submission creates prior art complications that narrow your available claims.
Software-as-medical-device (SaMD)
AI diagnostic algorithms, clinical decision support systems, and remote monitoring software involve novel technical methods. We draft method and system claims that survive both USPTO and potential IPR challenges.
Freedom-to-operate analysis
In medtech, one overlooked patent can derail a product launch or acquisition. We conduct FTO alongside prosecution to ensure your product path is clear - and identify licensing opportunities where it isn't.
FDA clearance is not a moat.
IP is.
Many health tech founders believe FDA clearance provides competitive protection. It doesn't. A competitor can follow the same regulatory path - and if you don't own the underlying IP, they can build a functionally identical product without infringing your clearance.
Real defensibility requires a patent portfolio covering the core innovation: the algorithm, the device architecture, the sensing method. We help you build that portfolio before clinical milestones create disclosure risks.
Healthcare IP has the highest stakes of any sector. A well-resourced medical device company that copies your innovation doesn't just hurt your revenue - it threatens patient access to better care.
“The best health tech exits are IP-driven. Acquirers pay for defensibility, not just revenue - because regulatory clearance alone is not a moat.”
Where we deploy
IP firepower.
Medical imaging AI, pathology, radiology, ophthalmology
Pre-validation filing, uncertainty quantificationNovel neural network architectures for medical image analysis, uncertainty quantification, and clinical workflow integration are patentable. We file before your validation studies create public disclosure.
Continuous monitoring, biosensors, implantables
Sensor fusion, low-power wireless, signal processingSensor fusion methods, form factor innovations, wireless protocols for low-power medical devices, and signal processing algorithms all contain patentable elements worth protecting early.
Robotic-assisted surgery, haptics, navigation
Force feedback, surgical planning, instrument trackingForce feedback systems, surgical planning algorithms, and instrument tracking methods are high-value patent targets in a market where Intuitive Surgical holds thousands of claims.
Software-based treatment, behavioral health, remote care
Therapeutic protocols, engagement algorithms, outcome modelsNovel therapeutic protocols delivered via software, engagement algorithms, and clinical outcome prediction models are patentable as method and system claims under current USPTO guidelines.
Health tech IP
protects patients too.
We co-invest $25K–$200K alongside top-tier leads in medical devices, diagnostics, and digital health. Our IP strategy accounts for FDA milestones, clinical trial disclosures, and the specific enforcement landscape in medtech.